September 22-25, 2026 as part of Biotech Week Boston
Hynes Convention CenterBoston, MA Laura StoppelPartner at RA Capital ManagementSpeaker
Profile
Laura Stoppel is a Partner on the Investment Team at RA Capital Management. Laura works on both public and private investments and serves as a Board Director for Artiva Biotherapeutics, Nimbus Therapeutics, and Acumen Pharmaceuticals. Previously, Laura covered hematologic malignancies, cell therapies, retinal diseases, and orphan neurodevelopmental disorders. Her graduate research investigated synaptic translation in syndromic autism. Laura holds a BA in Biology and Psychology from Harvard University and a PhD in Neuroscience from MIT.
Agenda Sessions
Investor Panel Discussion: Funding the Future- Investment Trends and Opportunities for Cell and Gene Therapies and Enabling Technologies
, 2:40pmView Session